Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 12.14B | 22.4x | 0.91 | SAR 151.80 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
Jamjoom Pharmaceuticals Factory | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 10.57B | 31.2x | 1.35 | SAR 153.80 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Saudi chemical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 7.17B | 24.2x | 0.42 | SAR 8.51 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPIMACO | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 3.04B | 120.2x | 0.82 | SAR 25.35 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.4% Upside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.58B | 32.3x | 1.52 | SAR 128.60 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.2% Downside | Upgrade to Pro+ | |
Qomel | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 420M | 15.2x | 0.17 | SAR 59.60 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almujtama Alraida Medical Co SJSC | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 285M | SAR 30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |